Amgen 2Q Profit Rises 40 Percent On Lower Costs

By: Associated Press Email
By: Associated Press Email

Stay up-to-date with KAKE News:

July 27, 2009

Amgen says its second-quarter profit rose 40 percent on lower costs and restructuring expenses as anemia drug sales continued falling.

The biotechnology company earned $1.27 billion, or $1.25 per share, up from profit of $906 million, or 84 cents per share, during the same period a year ago. Revenue fell 1 percent to $3.71 billion from $3.76 billion.

Excluding charges, the Thousand Oaks, Calif.-based company expected profit of $1.29 per share, while Wall Street forecast profit of $1.16 per share with just under $3.58 billion in revenue.

Amgen now expects 2009 profit between $4.80 and $4.95 per share, up from prior guidance of $4.55 to $4.75 per share.


Comments are posted from viewers like you and do not always reflect the views of this station.
powered by Disqus
KAKE TV 1500 N. West Street Wichita, KS 67203-1323 (316) 943-4221
Gray Television, Inc. - Copyright © 2002-2014 - Designed by Gray Digital Media - Powered by Clickability 51808542 - kake.com/a?a=51808542